Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
Authors
Keywords
-
Journal
Cancers
Volume 10, Issue 8, Pages 241
Publisher
MDPI AG
Online
2018-07-24
DOI
10.3390/cancers10080241
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- STAT3/PIAS3Levels Serve as “Early Signature” Genes in the Development of High-Grade Serous Carcinoma from the Fallopian Tube
- (2018) Uksha Saini et al. CANCER RESEARCH
- PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation
- (2018) Angela Russo et al. ONCOGENE
- Surface markers of cancer stem-like cells of ovarian cancer and their clinical relevance
- (2018) Aleksandra Klemba et al. Wspolczesna Onkologia-Contemporary Oncology
- Activation of hedgehog signaling and its association with cisplatin resistance in ovarian epithelial tumors
- (2018) Xueling Song et al. Oncology Letters
- JAK2/STAT3 pathway as a therapeutic target in ovarian cancers
- (2018) Tomoyuki Yoshikawa et al. Oncology Letters
- Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau
- (2018) Kristen Starbuck et al. Oncotarget
- Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy–Innovative Models Prolong Survival (OCTIPS) Consortium
- (2017) Ilary Ruscito et al. EUROPEAN JOURNAL OF CANCER
- Drug Resistance Driven by Cancer Stem Cells and Their Niche
- (2017) Marta Prieto-Vila et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ovarian cancer stem cells more questions than answers
- (2017) Petronella Beatrix Ottevanger SEMINARS IN CANCER BIOLOGY
- Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma
- (2017) Jennifer Ducie et al. Nature Communications
- LGR5 and LGR6 in stem cell biology and ovarian cancer
- (2017) Adam J. Schindler et al. Oncotarget
- Let-7d increases ovarian cancer cell sensitivity to a genistein analog by targeting c-Myc
- (2017) Ying-Xia Ning et al. Oncotarget
- hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells
- (2017) Saswati Karmakar et al. Oncotarget
- The Crosstalk between Ovarian Cancer Stem Cell Niche and the Tumor Microenvironment
- (2017) Manuel Varas-Godoy et al. Stem Cells International
- The Dualistic Model of Ovarian Carcinogenesis
- (2016) Robert J. Kurman et al. AMERICAN JOURNAL OF PATHOLOGY
- The prognostic value and clinicopathological significance of CD44 expression in ovarian cancer: a meta-analysis
- (2016) Luyang Zhao et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- NANOG regulates epithelial–mesenchymal transition and chemoresistance in ovarian cancer
- (2016) Shan Qin et al. BIOSCIENCE REPORTS
- Ovarian carcinoma diagnosis: the clinical impact of 15 years of change
- (2016) Stefan Kommoss et al. BRITISH JOURNAL OF CANCER
- Association of Vasculogenic Mimicry Formation and CD133 Expression with Poor Prognosis in Ovarian Cancer
- (2016) Jun Liang et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- Low-grade serous ovarian cancer: A review
- (2016) Anis Kaldawy et al. GYNECOLOGIC ONCOLOGY
- Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment
- (2016) Veronica Rojas et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study
- (2016) Alaa A. Elzarkaa et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism
- (2016) Eun Jin Seo et al. STEM CELLS
- Wnt5a Signaling in Cancer
- (2016) Marwa Asem et al. Cancers
- The NF-κB Pathway and Cancer Stem Cells
- (2016) Amanda Rinkenbaugh et al. Cells
- The Ovary Is an Alternative Site of Origin for High-Grade Serous Ovarian Cancer in Mice
- (2015) Jaeyeon Kim et al. ENDOCRINOLOGY
- Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma
- (2015) Claire Bonneau et al. GYNECOLOGIC ONCOLOGY
- Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?
- (2015) Esther Louise Moss et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
- (2015) Sean Kehoe et al. LANCET
- CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis
- (2015) D. Burgos-Ojeda et al. MOLECULAR CANCER THERAPEUTICS
- The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids
- (2015) Mirjana Kessler et al. Nature Communications
- Pathobiology of ovarian carcinomas
- (2015) Mojgan Devouassoux-Shisheboran et al. Chinese Journal of Cancer
- Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival
- (2015) Lisa K. Mullany et al. NEOPLASIA
- ARID3B increases ovarian tumor burden and is associated with a cancer stem cell gene signature
- (2015) Lynn Roy et al. Oncotarget
- The Epidermal Growth Factor Receptor Responsive miR-125a Represses Mesenchymal Morphology in Ovarian Cancer Cells
- (2015) Karen D. Cowden Dahl et al. NEOPLASIA
- PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
- (2014) HaiXia Li et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
- (2014) Khalid Abubaker et al. BMC CANCER
- Akt confers cisplatin chemoresistance in human gynecological carcinoma cells by modulating PPM1D stability
- (2014) Ahmed Y. Ali et al. MOLECULAR CARCINOGENESIS
- Lgr5 marks stem/progenitor cells in ovary and tubal epithelia
- (2014) Annie Ng et al. NATURE CELL BIOLOGY
- The Role of the PTEN/PI3K/Akt Pathway on Prognosis in Epithelial Ovarian Cancer: A Meta-Analysis
- (2014) J. Cai et al. ONCOLOGIST
- Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy
- (2014) Suping Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ROR1 expression correlated with poor clinical outcome in human ovarian cancer
- (2014) Huilin Zhang et al. Scientific Reports
- Recent Concepts of Ovarian Carcinogenesis: Type I and Type II
- (2014) Masafumi Koshiyama et al. Biomed Research International
- Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines
- (2014) Jennifer M. Cole et al. Jove-Journal of Visualized Experiments
- Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
- (2013) Ruth Perets et al. CANCER CELL
- Ovarian tumor initiating cell populations persist following paclitaxel and carboplatin chemotherapy treatment in vivo
- (2013) Kashmira Kulkarni-Datar et al. CANCER LETTERS
- Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway
- (2013) X. Luo et al. CELL PROLIFERATION
- The Molecular Fingerprint of High Grade Serous Ovarian Cancer Reflects Its Fallopian Tube Origin
- (2013) Mirjana Kessler et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma
- (2013) Hsien-Neng Huang et al. MODERN PATHOLOGY
- Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets
- (2013) Nuzhat Ahmed et al. MOLECULAR ASPECTS OF MEDICINE
- Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche
- (2013) Andrea Flesken-Nikitin et al. NATURE
- The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients
- (2013) Jiabo Di et al. CELLULAR ONCOLOGY
- ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome
- (2012) Yu-Chi Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- Ovarian cancer stem cell markers: Prognostic and therapeutic implications
- (2012) Daniela Burgos-Ojeda et al. CANCER LETTERS
- Ovarian cancer stem cells: Working towards the root of stemness
- (2012) Rosemary Foster et al. CANCER LETTERS
- Defining NOTCH3 Target Genes in Ovarian Cancer
- (2012) X. Chen et al. CANCER RESEARCH
- Cancer Stem Cells: Current Status and Evolving Complexities
- (2012) Jane E. Visvader et al. Cell Stem Cell
- Ovarian low-grade serous carcinoma: A comprehensive update
- (2012) Ivan Diaz-Padilla et al. GYNECOLOGIC ONCOLOGY
- Cancer stem cells
- (2012) Zuoren Yu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Cancerous ovarian stem cells: Obscure targets for therapy but relevant to chemoresistance
- (2012) Nuzhat Ahmed et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Embryonic Stem Cell Markers
- (2012) Wenxiu Zhao et al. MOLECULES
- Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1 and inhibition of platinum–DNA adduct repair
- (2012) K Kudo et al. ONCOGENE
- c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin–ATP-binding cassette G2 signaling
- (2012) W K Chau et al. ONCOGENE
- Identification of a Potential Ovarian Cancer Stem Cell Gene Expression Profile from Advanced Stage Papillary Serous Ovarian Cancer
- (2012) Vinod Vathipadiekal et al. PLoS One
- High-grade serous ovarian cancer arises from fallopian tube in a mouse model
- (2012) J. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations
- (2012) Iwona K. Rzepecka et al. Cancer Genetics
- Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment
- (2011) Maria V. Barbolina et al. BIOCHEMICAL JOURNAL
- Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
- (2011) I. A. Silva et al. CANCER RESEARCH
- Cancer Stem Cell Niche: The Place to Be
- (2011) T. Borovski et al. CANCER RESEARCH
- Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance
- (2011) Ayesha B. Alvero et al. CELL CYCLE
- Targeting the Notch Ligand Jagged1 in Both Tumor Cells and Stroma in Ovarian Cancer
- (2011) A. D. Steg et al. CLINICAL CANCER RESEARCH
- Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
- (2011) A. D. Steg et al. CLINICAL CANCER RESEARCH
- Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome
- (2011) Lijing Luo et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin
- (2011) Yoichi Kobayashi et al. GYNECOLOGIC ONCOLOGY
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis
- (2011) W. Glenn McCluggage PATHOLOGY
- Histologic, Molecular, and Cytogenetic Features of Ovarian Cancers: Implications for Diagnosis and Treatment
- (2011) Neeraj Lalwani et al. RADIOGRAPHICS
- Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3
- (2010) Li Ma et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Notch3 Overexpression Is Related to the Recurrence of Ovarian Cancer and Confers Resistance to Carboplatin
- (2010) Joon Tae Park et al. AMERICAN JOURNAL OF PATHOLOGY
- Regulation of Inflammation by the NF-κB Pathway in Ovarian Cancer Stem Cells
- (2010) Aliza L. Leizer et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?
- (2010) Christopher G. Przybycin et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant
- (2010) L Hu et al. BRITISH JOURNAL OF CANCER
- Targeting Hedgehog -- a Cancer Stem Cell Pathway
- (2010) A. A. Merchant et al. CLINICAL CANCER RESEARCH
- Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer
- (2010) Bryan T.J. Hennessy et al. JOURNAL OF CLINICAL ONCOLOGY
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
- (2010) Ahmed Ashour Ahmed et al. JOURNAL OF PATHOLOGY
- Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
- (2010) C. N. Landen et al. MOLECULAR CANCER THERAPEUTICS
- Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways
- (2010) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer
- (2010) S Peng et al. ONCOGENE
- CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
- (2010) M-Q Gao et al. ONCOGENE
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
- (2010) Siân Jones et al. SCIENCE
- Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant
- (2009) David M. Gershenson et al. GYNECOLOGIC ONCOLOGY
- Ovarian carcinoma pathology and genetics: recent advances
- (2009) C. Blake Gilks et al. HUMAN PATHOLOGY
- Histologic Subtypes of Ovarian Carcinoma
- (2009) Robert A. Soslow INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer
- (2009) Michael D. Curley et al. STEM CELLS
- Jagged-1 and Notch3 Juxtacrine Loop Regulates Ovarian Tumor Growth and Adhesion
- (2008) J.-H. Choi et al. CANCER RESEARCH
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation
- (2008) Xiaoyun Liao et al. CARCINOGENESIS
- Role of Hedgehog Signaling in Ovarian Cancer
- (2008) R. Bhattacharya et al. CLINICAL CANCER RESEARCH
- Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of -catenin in mice
- (2008) T. Grigoryan et al. GENES & DEVELOPMENT
- Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum
- (2008) Kathleen M. Schmeler et al. GYNECOLOGIC ONCOLOGY
- Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells
- (2008) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
- (2008) T Baba et al. ONCOGENE
- Ovarian cancer: emerging concept on cancer stem cells
- (2008) Moorthy P Ponnusamy et al. Journal of Ovarian Research
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started